Skip to main content
OpenTrials
Completed

NCT Number: NCT04488211

IVM Survey Among Reproductive Medicine Specialists

Although IVM as a laboratory technology in reproductive medicine has existed for many decades, there is a lack of well-designed studies comparing the efficiency and the patient satisfaction related to IVM as compared to standard ovarian stimulation for IVF. In view of this, and in order to identify unmet needs of fertility specialists with regard to the application of IVM, the investigator developed the idea of a worldwide web-based survey analysis of fertility specialists' insights and experiences regarding IVM.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

IVM

Sex eligibility

All sexes

Study type

Observational

Primary location

Universitair Ziekenhuis Brussel

Brussels, Belgium

About this study

The IVM survey will be structured as a series of open questions and multiple-choice questions. In most of the questions, a single answer will be required by participants. A small number of questions will allow multiple answers. The survey will be web-based. Invitations to participate in the survey will be emailed on three occasions to selected fertility specialists worldwide who are affiliated to a public or private fertility clinic. Clinics will be identified based on whether they have worked with IVM previously but stopped, and clinics with appropriate size to offer IVM competence. When no response is obtained from selected fertility specialists, e-mails will be sent to affiliated colleagues working at the same fertility clinic. When analyzing the survey results, care will be taken to analyse the responses per fertility clinic, as responses from different fertility specialists working in the same fertility clinic should be avoided. Results will be analysed using a method that assigns equal weight per clinic and a method that weights clinic responses based on treatment volume (number of IVF cycles).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • IVF clinics that have worked with IVM previously but stopped
  • clinics with appropriate size to offer IVM

Treatment and study plan

Survey

Other

The IVM survey will be structured as a series of open questions and multiple-choice questions.

Primary outcomes

  1. Name of the measurement: Application of in vitro maturation (IVM) of oocytes as a laboratory tool

    Time frame: 1 month

    Measurement tool: questionnaire; unit of measure: % of respondents who use oocyte in vitro maturation in the laboratory;

  2. Name of the measurement: Appreciation of IVM as a laboratory technique

    Time frame: 1 month

    Measurement tool: questionnaire; unit of measure: % of respondents who believe there is a role for IVM in the ART (assisted reproductive technology ) clinic

Secondary outcomes

  1. Name of the measurement: Annual number of egg retrievals for IVM

    Time frame: 1 month

    Measurement tool: questionnaire; unit of measure: number

Sponsors and collaborators

Lead sponsor

Universitair Ziekenhuis Brussel

Other

Collaborators

  • CooperSurgical Inc.

Registry information

Official study title

Survey of Fertility Specialists' Knowledge of, Experience With, and Attitudes Toward the Use of in Vitro Maturation of Oocytes in Reproductive Medicine

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jul 27, 2020
Registry last updated
May 4, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.